CRVL vs. NVO
CRVL (CorVel Corporation) and NVO (Novo Nordisk A/S) are both stocks. CRVL operates in Insurance Brokers (Financial Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CRVL returned 15.41%/yr vs 8.62%/yr for NVO. At a 0.15 correlation, their price movements are largely independent.
Performance
CRVL vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRVL achieves a -11.79% return, which is significantly lower than NVO's -3.54% return. Over the past 10 years, CRVL has outperformed NVO with an annualized return of 15.41%, while NVO has yielded a comparatively lower 8.62% annualized return.
CRVL
- 1D
- 3.63%
- 1M
- -4.86%
- YTD
- -11.79%
- 6M
- -12.27%
- 1Y
- -42.20%
- 3Y*
- -3.66%
- 5Y*
- 6.62%
- 10Y*
- 15.41%
NVO
- 1D
- 3.36%
- 1M
- 5.47%
- YTD
- -3.54%
- 6M
- -4.91%
- 1Y
- -28.81%
- 3Y*
- -13.64%
- 5Y*
- 5.10%
- 10Y*
- 8.62%
CRVL vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRVL CorVel Corporation | -11.79% | -39.18% | 35.02% | 70.10% | -30.13% | 96.23% | 21.34% | 41.54% | 16.67% | 44.54% |
NVO Novo Nordisk A/S | -3.54% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between CRVL and NVO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 1991 | 0.15 |
Fundamentals
CRVL:
$3.06B
NVO:
$210.96B
CRVL:
$2.14
NVO:
DKK 27.42
CRVL:
27.93
NVO:
11.31
CRVL:
1.89
NVO:
0.48
CRVL:
3.21
NVO:
4.21
CRVL:
7.76
NVO:
6.80
CRVL:
$958.53M
NVO:
DKK 327.80B
CRVL:
$232.86M
NVO:
DKK 268.30B
CRVL:
$166.41M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRVL vs. NVO — Risk / Return Rank
CRVL
NVO
CRVL vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorVel Corporation (CRVL) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRVL | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.46 | ||
| Sortino ratioReturn per unit of downside risk | -0.81 | ||
| Omega ratioGain probability vs. loss probability | 0.80 | 0.93 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | -0.59 | -0.17 |
| Martin ratioReturn relative to average drawdown | -1.19 | -0.93 | -0.25 |
Loading charts...
Drawdowns
CRVL vs. NVO - Drawdown Comparison
The maximum CRVL drawdown since its inception was -67.12%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for CRVL and NVO.
Loading charts...
Drawdown Indicators
| CRVL | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.12% | -74.70% | +7.58% |
Max Drawdown (1Y)Largest decline over 1 year | -56.07% | -49.17% | -6.90% |
Max Drawdown (3Y)Largest decline over 3 years | -64.19% | -74.70% | +10.51% |
Max Drawdown (5Y)Largest decline over 5 years | -64.19% | -74.70% | +10.51% |
Max Drawdown (10Y)Largest decline over 10 years | -64.19% | -74.70% | +10.51% |
Current DrawdownCurrent decline from peak | -53.53% | -65.54% | +12.01% |
Average DrawdownAverage peak-to-trough decline | -20.39% | -17.81% | -2.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.62% | 30.87% | +4.75% |
Volatility
CRVL vs. NVO - Volatility Comparison
CorVel Corporation (CRVL) and Novo Nordisk A/S (NVO) have volatilities of 12.22% and 12.04%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRVL | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.22% | 12.04% | +0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 39.26% | 38.41% | +0.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.41% | 52.06% | -10.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.40% | 38.48% | -5.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.39% | 32.58% | +1.81% |
Dividends
CRVL vs. NVO - Dividend Comparison
CRVL has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.80%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRVL CorVel Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 3.80% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
CRVL vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between CorVel Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRVL vs. NVO - Profitability Comparison
CRVL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorVel Corporation reported a gross profit of 63.01M and revenue of 248.55M. Therefore, the gross margin over that period was 25.4%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
CRVL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorVel Corporation reported an operating income of 39.72M and revenue of 248.55M, resulting in an operating margin of 16.0%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
CRVL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorVel Corporation reported a net income of 31.03M and revenue of 248.55M, resulting in a net margin of 12.5%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
CRVL and NVO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRVL has higher volatility (12.22%) compared to NVO (12.04%). In terms of maximum drawdown, CRVL dropped -67.12% vs NVO's -74.70%.
NVO currently has the higher Sharpe Ratio (-0.56 vs -1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRVL and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer